GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » Cyclically Adjusted PS Ratio

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Cyclically Adjusted PS Ratio : 4.09 (As of Jun. 07, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-07), Shijiazhuang Yiling Pharmaceutical Co's current share price is ¥17.79. Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥4.35. Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 4.09.

The historical rank and industry rank for Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:002603' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.22   Med: 6.46   Max: 14.09
Current: 4.18

During the past years, Shijiazhuang Yiling Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 14.09. The lowest was 3.22. And the median was 6.46.

SZSE:002603's Cyclically Adjusted PS Ratio is ranked worse than
76.85% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs SZSE:002603: 4.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Shijiazhuang Yiling Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥1.510. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥4.35 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.63 6.75 6.23 7.83 5.44

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.25 6.23 5.58 5.44 4.64

Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=17.79/4.35
=4.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Shijiazhuang Yiling Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.51/115.2271*115.2271
=1.510

Current CPI (Mar. 2024) = 115.2271.

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.941 98.200 1.104
201409 0.871 98.900 1.015
201412 0.454 99.000 0.528
201503 0.546 99.900 0.630
201506 0.547 99.500 0.633
201509 0.497 100.500 0.570
201512 0.468 100.600 0.536
201603 0.698 102.200 0.787
201606 0.613 101.400 0.697
201609 0.555 102.400 0.625
201612 0.561 102.600 0.630
201703 0.797 103.200 0.890
201706 0.534 103.100 0.597
201709 0.476 104.100 0.527
201712 0.628 104.500 0.692
201803 0.909 105.300 0.995
201806 0.678 104.900 0.745
201809 0.636 106.600 0.687
201812 0.585 106.500 0.633
201903 0.921 107.700 0.985
201906 0.859 107.700 0.919
201909 0.810 109.800 0.850
201912 0.907 111.200 0.940
202003 1.408 112.300 1.445
202006 0.713 110.400 0.744
202009 1.160 111.700 1.197
202012 1.398 111.500 1.445
202103 2.196 112.662 2.246
202106 1.334 111.769 1.375
202109 1.326 112.215 1.362
202112 1.201 113.108 1.224
202203 1.630 114.335 1.643
202206 1.702 114.558 1.712
202209 1.424 115.339 1.423
202212 2.746 115.116 2.749
202303 2.355 115.116 2.357
202306 1.709 114.558 1.719
202309 1.068 115.339 1.067
202312 1.044 114.781 1.048
202403 1.510 115.227 1.510

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shijiazhuang Yiling Pharmaceutical Co  (SZSE:002603) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Shijiazhuang Yiling Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Executives
Zhang Qiu Lian Directors, executives
Han Yue Zhi Executives
Zhao Shao Hua Executives
Wang Wei Executives
Gao Xue Dong Supervisors
Wu Yi Ling Director
Gao Xiu Qiang Executives
Wu Xiang Jun Directors, executives
Guo Shuang Geng Director
Wang Hua Securities Affairs Representative
Dai Feng Xiang Directors, executives
Liu Gen Wu Supervisors
Wang Wei Ping Directors, executives
Xu Wei Dong Director
Wu Rui Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines